Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action

Faidon Magkos, Stavros A. Kavouras

Research output: Contribution to journalReview article

168 Citations (Scopus)

Abstract

Caffeine is the most widely consumed psychoactive 'drug in the world and probably one of the most commonly used stimulants in sports. This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects. Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body. Peak plasma concentrations after normal consumption are usually around 50 M, and half-lives for elimination range between 2.5-10 h. The parent compound is extensively metabolized in the liver microsomes to more than 25 derivatives, while considerably less than 5% of the ingested dose is excreted unchanged in the urine. There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors. Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the observed effects of caffeine in humans in vivo . These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metabolism, as well as other, less thoroughly characterized actions. Not all, however, seem to account for the observed effects in vivo , although a variable degree of contribution cannot be readily discounted on the basis of experimental data. The most physiologically relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochemical mechanisms may also be operational.

Original languageEnglish (US)
Pages (from-to)535-562
Number of pages28
JournalCritical reviews in food science and nutrition
Volume45
Issue number7-8
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Caffeine
Pharmacokinetics
caffeine
Sports
sports
pharmacokinetics
mechanism of action
Enzyme inhibition
Purinergic P1 Receptors
adenosine
Liver
Muscle
ergogenic aids
Isoenzymes
Glycogen Phosphorylase
muscle strength
Sodium-Potassium-Exchanging ATPase
Muscles
receptors
sarcoplasmic reticulum

Keywords

  • Caffeine
  • In vitro
  • Metabolism
  • Pharmacokinetics
  • Xanthines

ASJC Scopus subject areas

  • Food Science
  • Industrial and Manufacturing Engineering

Cite this

Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. / Magkos, Faidon; Kavouras, Stavros A.

In: Critical reviews in food science and nutrition, Vol. 45, No. 7-8, 01.10.2005, p. 535-562.

Research output: Contribution to journalReview article

@article{e118a8dd6c5441d39eaa7a6c0f172cb6,
title = "Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action",
abstract = "Caffeine is the most widely consumed psychoactive 'drug in the world and probably one of the most commonly used stimulants in sports. This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects. Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body. Peak plasma concentrations after normal consumption are usually around 50 M, and half-lives for elimination range between 2.5-10 h. The parent compound is extensively metabolized in the liver microsomes to more than 25 derivatives, while considerably less than 5{\%} of the ingested dose is excreted unchanged in the urine. There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors. Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the observed effects of caffeine in humans in vivo . These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metabolism, as well as other, less thoroughly characterized actions. Not all, however, seem to account for the observed effects in vivo , although a variable degree of contribution cannot be readily discounted on the basis of experimental data. The most physiologically relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochemical mechanisms may also be operational.",
keywords = "Caffeine, In vitro, Metabolism, Pharmacokinetics, Xanthines",
author = "Faidon Magkos and Kavouras, {Stavros A.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1080/1040-830491379245",
language = "English (US)",
volume = "45",
pages = "535--562",
journal = "Critical Reviews in Food Science and Nutrition",
issn = "1040-8398",
publisher = "Taylor and Francis Ltd.",
number = "7-8",

}

TY - JOUR

T1 - Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action

AU - Magkos, Faidon

AU - Kavouras, Stavros A.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Caffeine is the most widely consumed psychoactive 'drug in the world and probably one of the most commonly used stimulants in sports. This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects. Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body. Peak plasma concentrations after normal consumption are usually around 50 M, and half-lives for elimination range between 2.5-10 h. The parent compound is extensively metabolized in the liver microsomes to more than 25 derivatives, while considerably less than 5% of the ingested dose is excreted unchanged in the urine. There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors. Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the observed effects of caffeine in humans in vivo . These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metabolism, as well as other, less thoroughly characterized actions. Not all, however, seem to account for the observed effects in vivo , although a variable degree of contribution cannot be readily discounted on the basis of experimental data. The most physiologically relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochemical mechanisms may also be operational.

AB - Caffeine is the most widely consumed psychoactive 'drug in the world and probably one of the most commonly used stimulants in sports. This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects. Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body. Peak plasma concentrations after normal consumption are usually around 50 M, and half-lives for elimination range between 2.5-10 h. The parent compound is extensively metabolized in the liver microsomes to more than 25 derivatives, while considerably less than 5% of the ingested dose is excreted unchanged in the urine. There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors. Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the observed effects of caffeine in humans in vivo . These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metabolism, as well as other, less thoroughly characterized actions. Not all, however, seem to account for the observed effects in vivo , although a variable degree of contribution cannot be readily discounted on the basis of experimental data. The most physiologically relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochemical mechanisms may also be operational.

KW - Caffeine

KW - In vitro

KW - Metabolism

KW - Pharmacokinetics

KW - Xanthines

UR - http://www.scopus.com/inward/record.url?scp=29344456972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29344456972&partnerID=8YFLogxK

U2 - 10.1080/1040-830491379245

DO - 10.1080/1040-830491379245

M3 - Review article

C2 - 16371327

AN - SCOPUS:29344456972

VL - 45

SP - 535

EP - 562

JO - Critical Reviews in Food Science and Nutrition

JF - Critical Reviews in Food Science and Nutrition

SN - 1040-8398

IS - 7-8

ER -